Trametinib is a highly potent (IC50 uMEK1 = 0.7 nM, pp-MEK1 = 14.9 nM)1 and selective MEK inhibitor displaying selective inhibition of proliferation in various BRAF mutant cancer cell lines (IC50 ACHN = 9.8 nM, IC50 HT-29 = 0.57 nM)2. It is approved for
* VAT and and shipping costs not included. Errors and price changes excepted
